| Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033) |
|---|
| 01/20/2004 | US6680387 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 01/20/2004 | CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 01/15/2004 | US20040010155 Oxidation of flumethasone; chemical intermediate for fluticasone propionate |
| 01/07/2004 | CN1133643C Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives |
| 01/02/2004 | EP1372666A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial / matrix adhesion such as asthma, cystic fibrosis and influenza |
| 12/31/2003 | WO2004001369A2 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |
| 12/31/2003 | WO2003047329A3 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 12/31/2003 | CN1132830C Method for extracting protein, short peptide, nucleic acid, isoflavone, saponin and oligosaccharide by using high and low temperature soybean cake |
| 12/25/2003 | US20030236408 Estrogenic compounds as anti-mitotic agents |
| 12/25/2003 | US20030236227 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 12/23/2003 | US6667299 16-alpha-bromo-3-beta-hydroxy-5-alpha-androstan-17-one hemihydrate; 16-alpha-bromoepiandrosterone; steroid; immune modulator |
| 11/27/2003 | US20030220309 17-methylenandrostan-3alpha-ol analogs as CRH inhibitors |
| 11/20/2003 | WO2003082896A3 A PROCESS FOR THE PREPARATION OF 6α-FLUORO STEROIDS BY ISOMERISATION OF 6β-FLUOROSTEROIDS |
| 11/11/2003 | US6645955 3,6-dihydroxy-24-amidyl steroid derivatives |
| 10/30/2003 | WO2003047329A8 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 10/28/2003 | US6638923 Estra-1,3,5(10),16-tetraene derivatives |
| 10/09/2003 | WO2003082896A2 A PROCESS FOR THE PREPARATION OF 6α-FLUORO STEROIDS BY ISOMERISATION OF 6β-FLUOROSTEROIDS |
| 10/09/2003 | CA2480629A1 A process for the preparation of 6.alpha.-fluoro steroids by isomerisation of 6.beta.-fluorosteroids |
| 09/23/2003 | US6623933 Methods for identifying a subunit specific modulator of N-methyl-D-asparate receptor |
| 09/17/2003 | EP1343803A2 2-substituted estrogens as antiangiogenic agents |
| 09/17/2003 | CN1121409C Process for preparing medicine |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/04/2003 | WO2003072592A1 17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents |
| 08/28/2003 | US20030162959 Reacting 17-hydroxy-9 beta ,11 beta -epoxy-16- beta -methyl-pregna-1,4-diene-3,20-dione 21-acetate compound with a stereoselective fluorinating agent to stereoselectively form a 21-ester, 17-hydroxy 6 alpha -fluorinated compound |
| 08/27/2003 | CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group |
| 08/26/2003 | US6610675 Inactive metabolite approach to soft drug design |
| 08/21/2003 | US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 08/20/2003 | EP1335928A1 Selective glucocorticoid receptor agonists |
| 08/20/2003 | CN1437610A Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17.Beta-carboxylic acid |
| 08/14/2003 | WO2003066656A1 Crystalline complexes of fluticasone 2-furoate |
| 08/14/2003 | WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | WO2003066032A1 Formulations for inhalation |
| 08/14/2003 | WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 08/14/2003 | WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | US20030153544 Fatty acid derivatives |
| 08/14/2003 | US20030153542 Novel anti-inflammatory androstane derivative compositions |
| 08/13/2003 | EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 08/07/2003 | WO2003064445A1 17-alpha-heterocyclic esters of androstane derivatives having anti-inflammatory activity |
| 07/29/2003 | CA2098804C Process for the preparation of a delta 9(11) steroid compound |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 06/26/2003 | WO2003051903A1 Androstane derivative having substituent in 7- and 17-positions |
| 06/17/2003 | US6579864 Arthritic diseases and/or autoimmune diseases |
| 06/12/2003 | WO2003047329A2 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 06/12/2003 | CA2473471A1 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 05/22/2003 | WO2003024943A3 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/01/2003 | US20030083231 Used of androstane derivatives in treatment of conditions such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/17/2003 | US20030073676 Dissolving in aqueous carrier; antiallergens |
| 04/16/2003 | EP1301526A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 04/10/2003 | WO2003029268A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/08/2003 | CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors |
| 04/03/2003 | US20030064972 Using thiazolidinone compound |
| 03/27/2003 | WO2003024943A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 03/27/2003 | US20030060425 Immune modulation method using steroid compounds |
| 03/27/2003 | CA2460150A1 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/13/2003 | WO2002042319A3 2-substituted estrogens as antiangiogenic agents |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/06/2003 | US20030045514 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 03/04/2003 | US6528666 C3 protecting 9,11-epoxy-17,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione,21-acetate; fluorinating at 6 alpha; depro-tecting and fluorinating epoxy group; simultaneous hydrolysis and oxidative degradation with methanolic potassium hydroxide |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/06/2003 | US20030027798 For therapy |
| 01/22/2003 | EP1276730A2 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 12/19/2002 | WO2002100878A1 Preparation of flumethasone and its 17-carboxyl androsten analogue |
| 12/05/2002 | US20020183532 Bioavailable prodrugs of androgenic steroids and related method |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 11/28/2002 | US20020177581 Novel anti-inflammatory androstane derivative |
| 11/27/2002 | CN1381444A Method for preparing flixonase and its correlative 17 bata-carbothionate using carbothioic acid synthetic method and extraction method |
| 11/21/2002 | US20020173496 Formulation containing novel anti-inflammatory androstane derivative |
| 11/20/2002 | EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 11/14/2002 | WO2002089814A1 17-METHYLENE-ANDROSTAN-3α-OL ANALOGS AS CRH INHIBITORS |
| 11/14/2002 | CA2484596A1 17-methylene-androstan-3alpha-ol analogs as crh inhibitors |
| 11/07/2002 | US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 10/03/2002 | US20020143001 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 10/02/2002 | CN1371912A Androstanol alkyl carbonic ether compound and preparation process thereof |
| 09/19/2002 | WO2002072108A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial/matrix adhesion such as asthma, cystic fibrosis and influenza |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/18/2002 | EP1240179A2 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/01/2002 | US20020103391 17-methyleneandrost-4-en-3 alpha-ol for example; anxiolytic agents; ligand semiochemicals which bind to neuroepithelial receptors |
| 07/31/2002 | EP1226155A2 18-nor-steroids as selectively active estrogens |
| 07/10/2002 | EP1220867A1 Process to prepare androst-4-en-17-carboxylic acid |
| 07/03/2002 | CN1357003A 类固醇衍生物 Steroid derivatives |
| 07/02/2002 | CA2064478C Ophthalmic composition |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/25/2002 | US6410760 Process to prepare androst-4-en-17-carboxylic acid |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/12/2002 | EP1212618A1 Effect of steroids on nmda receptors depends on subunit composition |
| 06/06/2002 | WO2002014343A8 Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents |
| 06/04/2002 | US6399767 Intermediates for the synthesis of vitamin D and steroid derivatives and process for preparation thereof |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | US20020065256 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |